| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |